---
document_datetime: 2023-09-21 19:36:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zirabev-epar-all-authorised-presentations_en.pdf
document_name: zirabev-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7450802
conversion_datetime: 2025-12-28 00:02:39.017773
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/18/1344/001 | Zirabev           | 100mg/4ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 4ml (25mg/ml)             | 1 vial      |
| EU/1/18/1344/002 | Zirabev           | 400mg/16ml | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 16ml (25mg/ml)            | 1 vial      |